Estimated antiretroviral therapy coverage among people living with HIV in Chad
Chad: Estimated antiretroviral therapy coverage among people living with HIV was 73.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Chad, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Chad recorded 73.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025. That is the highest value across all 26 years on record.
The figure is up 12.3% on the previous year and up 135.5% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Chad peaked at 73.0% in 2025 and was at its lowest, 0.0%, in 2000.
That places Chad 75th out of 143 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Chad, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 1.0% | — |
| 2006 | 4.0% | +300.0% |
| 2007 | 7.0% | +75.0% |
| 2008 | 10.0% | +42.9% |
| 2009 | 13.0% | +30.0% |
| 2010 | 16.0% | +23.1% |
| 2011 | 19.0% | +18.8% |
| 2012 | 22.0% | +15.8% |
| 2013 | 25.0% | +13.6% |
| 2014 | 28.0% | +12.0% |
| 2015 | 31.0% | +10.7% |
| 2016 | 34.0% | +9.7% |
| 2017 | 37.0% | +8.8% |
| 2018 | 40.0% | +8.1% |
| 2019 | 43.0% | +7.5% |
| 2020 | 47.0% | +9.3% |
| 2021 | 52.0% | +10.6% |
| 2022 | 55.0% | +5.8% |
| 2023 | 59.0% | +7.3% |
| 2024 | 65.0% | +10.2% |
| 2025 | 73.0% | +12.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.5% | 0.0% | 13.0% | 10 |
| 2010s | 29.5% | 16.0% | 43.0% | 10 |
| 2020s | 58.5% | 47.0% | 73.0% | 6 |
Countries ranked near Chad
More health data for Chad
- Un projection of annual infant deaths, annual growth rate -0.9964 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6578 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,071 deaths per 1,000 people (2090)
- Number of infants who die before age 1 41,435 deaths (2100)
- Population ages 30-34, female, annual growth rate 4.48 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0314 units per person (2025)
- Population ages 30-34, male, annual growth rate 4.52 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0314 units per person (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Chad?
- Estimated antiretroviral therapy coverage among people living with hiv in Chad was 73.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Chad?
- The highest recorded value was 73.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Chad?
- The lowest recorded value was 0.0% in 2000.
- How does Chad rank for estimated antiretroviral therapy coverage among people living with hiv?
- Chad ranks 75th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Chad?
- Over the last ten years it is up 135.5%. The long-run trend across the full record is volatile.
- Where does this Chad data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).